797(top 1%)
papers
44.6K(top 0.1%)
citations
99(top 0.1%)
h-index
183(top 0.1%)
g-index
859
all documents
47.6K
doc citations
4.0K
citing journals

Top Articles

#TitleJournalYearCitations
1Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine20093,540
2Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upLancet, The20141,261
3Prostate-Cancer Mortality at 11 Years of Follow-upNew England Journal of Medicine20121,105
4Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community AnnotationPLoS Biology20121,064
5Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)Lancet, The2012759
6Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociNature Genetics2018652
7Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyEuropean Urology2017638
8Long Noncoding RNA in Prostate, Bladder, and Kidney CancerEuropean Urology2014601
9Reporting and Interpreting Decision Curve Analysis: A Guide for InvestigatorsEuropean Urology2018590
10Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysisEuropean Urology2015569
11Active Surveillance for Prostate Cancer: A Systematic Review of the LiteratureEuropean Urology2012518
12Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS StudyEuropean Urology2013450
13EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-GuérinEuropean Urology2016445
14EAU Guidelines on Neurogenic Lower Urinary Tract DysfunctionEuropean Urology2009429
15A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen RangeJournal of Urology2011408
16Summary of European Association of Urology (EAU) Guidelines on Neuro-UrologyEuropean Urology2016406
17Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD TrialEuropean Urology2019375
18The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of InflammationEuropean Urology2011351
19The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewEuropean Urology2017348
20Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the BladderEuropean Urology2010347
21ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical PracticeEuropean Urology2009332
22Widespread and Functional RNA Circularization in Localized Prostate CancerCell2019317
23Androgens and male fertilityWorld Journal of Urology2003305
24A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active TreatmentEuropean Urology2016290
25Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2010279
26Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy CohortEuropean Urology2012277
27Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic NomogramJournal of Urology2007271
28Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized TrialEuropean Urology2012269
29Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk predictionNature Genetics2021264
30Exosomes as Biomarker Treasure Chests for Prostate CancerEuropean Urology2011246
31The Potential of MicroRNAs as Prostate Cancer BiomarkersEuropean Urology2016243
32Male infertility in cancer patients: Review of the literatureInternational Journal of Urology2010242
33Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancerOncogene2012239
34Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancerModern Pathology2015239
35European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 EraEuropean Urology2020239
36Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancerThe Cochrane Library2019234
37The Prostate Health Index Selectively Identifies Clinically Significant Prostate CancerJournal of Urology2015228
38Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer DetectionEuropean Urology2010223
39Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor CellsEuropean Urology2015223
40Extracellular Vesicle Quantification and Characterization: Common Methods and Emerging ApproachesBioengineering2019219
41Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)European Urology2012216
42The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer PatientsEuropean Urology2017213
43Contemporary Role of Androgen Deprivation Therapy for Prostate CancerEuropean Urology2012206
44The Mutational Landscape of Prostate CancerEuropean Urology2013203
45Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisEuropean Urology2019203
46Anxiety and distress during active surveillance for early prostate cancerCancer2009193
47Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate CancerEuropean Urology2015190
48Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancerEuropean Journal of Cancer2013183
49Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular VesiclesJournal of Extracellular Vesicles2021182
50Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)European Urology2009180